Alzheimer dementia with sparse amyloid–AD mimic or variant?
Author of publication
Alberto Serrano-Pozo and Bradley T. Hyman
Date of publication
Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer’s disease peripheral biomarker
Supporting Payer Treatment Reimbursement Decisions for Alzheimer’s Disease: DISCERN™ Test Provides Definitive Diagnosis of Alzheimer’s Disease and Degenerative Pathologies vs. Other Forms of Dementia
ISPOR Annual Conference: 90% of Physicians Follow Results of DISCERN, First Skin Test for Alzheimer’s Disease
May is Older Americans Month: Definitive Diagnosis of Alzheimer’s Disease Helps More Americans Get the Support They Need Sooner
SYNAPS Dx Joins American Brain Coalition, Advocates for More Research, Better Treatment and Support for People with Brain Disorders
Semler Scientific Investment Advances Market Positioning and Confidence in SYNAPS Dx
DISCERN™ Video Showcases Benefits of First Accurate, Autopsy-Confirmed Test for Alzheimer’s Disease
Input your search keywords and press Enter.